Addressing the COVID-19 Crisis: An Open Forum Webinar ... · American Pharmacists Association...

American Pharmacists Association

Addressing the COVID-19 Crisis: An Open Forum

Webinar Series for Pharmacists

April 16, 2020


Michael D. Hogue, PharmD, FAPHA, FNAPDean and ProfessorLoma Linda University School of PharmacyPresident, APhA

Host and Moderator


Today’s Focus:

Highlight physician perspectives on COVID-19 and physician and pharmacist collaboration opportunities

Update on changes to pharmacist and pharmacy practice authorities in the states to address the COVID-19 pandemic


John W. Kennedy, M.D.Chief Medical OfficerAmerican Medical Group Association (AMGA)PresidentAmerican Medical Group Foundation (AMGF)

Guest speaker


Rebecca P. Snead, RPh, FAPhAChief Executive Officer, Executive Vice PresidentNational Alliance of State Pharmacy Associations (NASPA)

Guest Speaker


Ilisa BG Bernstein, PharmD, JD, FAPhASenior Vice President, Pharmacy Practice and Government AffairsAmerican Pharmacists Association

Subject Matter Expert: Q&A


Daniel Zlott, PharmD, BCOPVice President, Professional Education ResourcesAmerican Pharmacists Association

Subject Matter Expert: Q&A


Format for Today’s Webinar 1:00 pm: Introductions1:05 pm: Discussion with John Kennedy, Chief Medical Officer,

AMGA (American Medical Group Association) and President, AMGA Foundation

1:15 pm: Discussion with Rebecca Snead, Executive Vice President and CEO, National Alliance of State Pharmacy Associations (NASPA)

1:25 pm: Open Forum: A Minute for Your Thoughts 1:50 pm: Wrap Up: Review of APhA’s Ongoing Activities and What’s

Coming


Discussion with John Kennedy

Physician perspectives on COVID-19 and perspectives on physician and pharmacist collaboration opportunities


Discussion with Rebecca Snead

An update on changes to pharmacist and pharmacy practice authorities in the states to address the COVID-19 pandemic


State Policy Map For Compounding of Hand Sanitizer

HI

AK

DCMOWV

MS

NH

NC

FL

KY

WA

SC

OH

CAMDDE

TN

MANYRI

IL

CT

VT

NJMI

ME

MN

GuidanceNo Action at This Time

ORID

MT ND

SD

NVUT

AZ NM

TX

WY

CO

NE

OK

KS

IA

WI

IN

PA

VA

AR

AL GA

LA

Based on data collected by NASPA (Updated 04/15/2020)


State Policy Map For Hydroxychloroquine/Chloroquine/Azithromycin

HI

AK

DCMOWV

MS

NH

NC

FL

KY

WA

SC

OH

CAMDDE

TN

MANYRI

IL

CT

VT

NJMI

ME

MN

No Action Taken

Requirements in-placeUse Professional Judgement

ORID

MT ND

SD

NVUT

AZ NM

TX

WY

CO

NE

OK

KS

IA

WI

IN

PA

VA

AR

AL GA

LA



State Policy Map For Therapeutic Interchange

HI

AK

DCMOWV

MS

NH

NC

FL

KY

WA

SC

OH

CAMDDE

TN

MANYRI

IL

CT

VT

NJMI

ME

MN

No Action Taken

Pre-Existing AuthorityEmergency Authority

ORID

MT ND

SD

NVUT

AZ NM

TX

WY

CO

NE

OK

KS

IA

WI

IN

PA

VA

AR

AL GA

LA


Pre-Existing + Emergency Authority


Is communication with physicians during COVID-19:A. EasierB. The sameC. HarderD. Not applicable to my position

Polling Question


• Use the Questions field on the GoToWebinar toolbar to submit comments and questions related to the topic discussion

• Individuals whose submissions are selected will be asked by the moderator to state the comment or question for the audience. The line for the individual will be unmuted to read their comment or question.

• To maximize the number of questions/comments addressed, a 60-second time limit will be in effect for everyone to state their question or comment.

• We will try to get to as many comments and questions as possible. We have created a new forum for COVID-19 discussions where further discussion post-webinar. Information on participating in this forum will be provided at the end of the open forum.

Open Forum Ground Rules


Open Forum Discussion: A Minute for Your Thoughts

Comments, Questions, Feedback


Review of APhA’s Ongoing Activities and What’s Coming


NEW Episodes – APhA’s 15 on COVID-19

An education series designed to help you sort COVID-19 fact from fiction. Each episode is 15-20 minutes and provides CPE.

Episode 7: Testing in COVID-19 (4/10) • http://elearning.pharmacist.com/products/

6060/15-on-covid-19-for-4-10-2020-testing?sectionId=a564dc9e-c912-4240-922c-b16b8bde614a

Episode 8: Convalescent Plasma in COVID-19 (4/13)• http://elearning.pharmacist.com/Activity/

Detail?productId=ba14dac8-33ac-4900-9ea4-3c88c8455298

http://elearning.pharmacist.com/products/6060/15-on-covid-19-for-4-10-2020-testing?sectionId=a564dc9e-c912-4240-922c-b16b8bde614a

http://elearning.pharmacist.com/Activity/Detail?productId=ba14dac8-33ac-4900-9ea4-3c88c8455298


In the past week….• FDA Meeting: APhA and other pharmacy organizations met with FDA on 4/10/20 to discuss drug

shortages, compounding, drug supply chain, fraudulent COVID products, hydroxychloroquine/chloroquine, and new legal authorities for COVID response.

• Pharmacist Safety:• OSHA guidance: APhA reached out to OSHA on 4/1/20 requesting more specific guidance

for pharmacies/pharmacists. On 4/8/20, OSHA issued updated guidance that encompasses pharmacy personnel.

• CDC guidance: APhA has been working with CDC to provide additional pharmacy/pharmacist specific safety measures. Update includes guidance for face coverings for customers, pharmacy personnel, postpone/reschedule preventative services such as adult immunizations, more info on cleaning/disinfecting.

• Pharmacist COVID testing: We are advocating to reduce barriers to implementing HHS issued guidance authorizing licensed pharmacists to order and administer COVID-19 tests, including logistics, payment, billing, and more.

• HEROS Fund: Reached out to Senator Schumer regarding including pharmacists as medical professionals in the legislation addressing hazard pay for essential workers.

G


Check out the practice resources here• COVID-19: Vaccination Basics• Demystifying Testing for SARS-CoV-2

Virus: Frequently Asked Questions• Managing Suspected Cases of COVID-

19 in Ambulatory Care/Community Pharmacy Settings

• New resources weekly!

pharmacist.com/coronavirus/practice-resources

https://www.pharmacist.com/coronavirus/practice-resources

https://www.pharmacist.com/coronavirus/practice-resources


COVID-19: Financial ConsiderationsIn these unprecedented times, we understand there are a lot of financial concerns you may be having. Emotions of fear and anxiety are rampant. Many people, including health care professionals, are temporarily out of work, markets are tanking, and interest rates are fluctuating all over. You may be wondering what you should be doing with your investments, how President Trump's changes to student loans affect your game plan, and whether you should refinance your home right now.

In this webinar, CERTIFIED FINANCIAL PLANNER™ Tim Baker addresses questions and concerns surrounding investment guidance, work uncertainty, student loan repayment, and more.

pharmacist.com/covid-19-financial-considerations

https://www.pharmacist.com/covid-19-financial-considerations


Post on ENGAGEPharmacy’s Response to COVID-19

POST your questions

SHARE your lessons learned

SUPPORT your colleagues

ACCESS the latest information

Are you immunizing patients in your

community-based pharmacy?

What is your biggest practice challenge during

COVID-19?


• Weekly webinar #5 will be on Thursday, April 23, from 1-2 pm ET

• The webinar recording and slides will be available within 24 hours

Join UsSame day, Same time, Same Place

https://www.pharmacist.com/coronavirus/resources-training

https://www.pharmacist.com/coronavirus/resources-training

Addressing the COVID-19 Crisis: An Open Forum Webinar ... · American Pharmacists Association...

Documents

Transcript of Addressing the COVID-19 Crisis: An Open Forum Webinar ... · American Pharmacists Association...